scholarly journals Potential and Prophylactic Use of Plants Containing Saponin-Type Compounds as Antibiofilm Agents against Respiratory Tract Infections

2021 ◽  
Vol 2021 ◽  
pp. 1-14
Author(s):  
I. Irem Tatli Cankaya ◽  
E. Inci Somuncuoglu
Keyword(s):  
Respiratory Tract ◽  
Antimicrobial Agents ◽  
Antimicrobial Properties ◽  
Antimicrobial Activities ◽  
Antibiofilm Activity ◽  
Upper Respiratory Tract ◽  
Lung Infections ◽  
Prophylactic Use ◽  
Tract Infections ◽  
Antibiofilm Agents

Epidemic diseases have been observed in every period of human history, and the treatment process has taken time. Causative microorganisms reproduce as biofilm and contribute to the emergence of various infectious diseases. The process that starts with respiratory disorders causes serious lung infections due to bacteria and viruses that accumulate and multiply. The biofilms are difficult to eliminate and show increased resistance to available antimicrobial agents. There is a need to identify and develop potential resources used in treatment. The search for novel biological agents from plants is gaining popularity due to the high abundance, accessibility with consequent lower cost for discovery, and lesser side effects and toxicity. Saponins found in some plants can be alternative to antibiotics, with antimicrobial activities. This review focused on the potency of saponin-containing plants with antimicrobial properties as antibiofilm agents against these infections. For this purpose, keywords were scanned in Web of Science, Scopus, and Google academics databases, and the related literature was compiled. Approximately, 25 plant taxa belonging to 18 families traditionally used in the treatment of respiratory diseases are listed. These taxa mostly belong to Fabaceae, Asteraceae, Apiaceae, and Asparagaceae families, respectively. Most of these taxa have antibacterial, antifungal, antitussive, and anti-inflammatory activities. Especially, plants with antibiofilm activity that can be effective against many microorganisms are compiled in this study. These plants can prevent or treat upper respiratory tract diseases caused by bacteria due to the phytochemicals they contain, especially saponins.

Principles of Judicious Use of Antimicrobial Agents for Pediatric Upper Respiratory Tract Infections

PEDIATRICS ◽  
1998 ◽  
Vol 101 (Supplement_1) ◽  
pp. 163-165 ◽  
Author(s):  
Scott F. Dowell ◽  
S. Michael Marcy ◽  
William R. Phillips ◽  
Michael A. Gerber ◽  
Benjamin Schwartz
Keyword(s):  
Respiratory Tract ◽  
Antimicrobial Agents ◽  
Respiratory Infections ◽  
The United States ◽  
Antimicrobial Treatment ◽  
Antimicrobial Use ◽  
Upper Respiratory Tract ◽  
Oral Agents ◽  
Upper Respiratory ◽  
Tract Infections

This article introduces a set of principles to define judicious antimicrobial use for five conditions that account for the majority of outpatient antimicrobial use in the United States. Data from the National Center for Health Statistics indicate that in recent years, approximately three fourths of all outpatient antibiotics have been prescribed for otitis media, sinusitis, bronchitis, pharyngitis, or nonspecific upper respiratory tract infection.1Antimicrobial drug use rates are highest for children1; therefore, the pediatric age group represents the focus for the present guidelines. The evidence-based principles presented here are focused on situations in which antimicrobial therapy could be curtailed without compromising patient care. They are not formulated as comprehensive management strategies. For most upper respiratory infections that require antimicrobial treatment, there are several appropriate oral agents from which to choose. Although the general principles of selecting narrow-spectrum agents with the fewest side effects and lowest cost are important, the principles that follow include few specific antibiotic selection recommendations.

The Role of Bacterial Interference in Otitis, Sinusitis and Tonsillitis

2005 ◽  
Vol 133 (1) ◽  
pp. 139-146 ◽  
Author(s):  
Itzhak Brook
Keyword(s):  
Respiratory Tract ◽  
Respiratory Tract Infections ◽  
Antimicrobial Agents ◽  
Bacterial Flora ◽  
Upper Respiratory Tract ◽  
Bacterial Strains ◽  
Upper Respiratory ◽  
Tract Infections ◽  
Bacterial Interference

Bacterial interactions that include antagonism (interference) and synergism help maintain balance between the members of the normal endogenous flora. Alpha-streptococci that predominate in the normal respiratory tract flora attracted most attention in studies of bacterial interference. Other organisms that possess interfering characteristics in upper respiratory tract infections (URTIs) are nonhemolytic streptococci, and Prevotella and Peptostreptococcus spp. The production of bacteriocins by some microorganisms is one of the important mechanisms of interference. The role of bacterial interference in the development of URTI and its effect on the eradication of these infections is discussed. These infections include pharyngo-tonsillitis, otitis media, and sinusitis. Treatment with various antimicrobial agents can affect the balance between members of the oro-pharyngeal bacterial flora and interfering organisms. Implantation into the indigenous microflora of low virulence bacterial strains that are potentially capable of interfering with colonization and infection with other more virulent organisms has been used in preliminary studies as a means of coping with the failure of antimicrobials in the treatment of several URTI.

scholarly journals Antimicrobial and Antibiofilm Activities of Weissella cibaria Against Pathogens of Upper Respiratory Tract Infections

2021 ◽  
Vol 9 (6) ◽  
pp. 1181
Author(s):  
Ji-Eun Yeu ◽  
Hyeon Gyu Lee ◽  
Geun-Yeong Park ◽  
Jisun Lee ◽  
Mi-Sun Kang
Keyword(s):  
Respiratory Tract ◽  
Respiratory Tract Infections ◽  
Antimicrobial Activities ◽  
Laser Scanning Microscopy ◽  
Upper Respiratory Tract Infections ◽  
Upper Respiratory Tract ◽  
Weissella Cibaria ◽  
Prevention And Treatment ◽  
Upper Respiratory ◽  
Tract Infections

Recently discovered preventive effects of probiotics on oral health have attracted interest to their use for the prevention and treatment of various diseases. This study aimed to evaluate the antimicrobial and antibiofilm properties of Weissella cibaria against Streptococcus pyogenes, Staphylococcus aureus, S. pneumoniae, and Moraxella catarrhalis, the major pathogens of upper respiratory tract infections (URTIs). The antimicrobial activities of W. cibaria were compared with those of other oral probiotics using a competitive inhibition assay and the determination of the minimum inhibitory concentrations (MICs). In addition, a time-kill assay, spectrophotometry, and confocal laser scanning microscopy were used to confirm the antimicrobial and antibiofilm abilities of W. cibaria CMU (oraCMU) and CMS1 (oraCMS1). Both live cells and cell-free supernatants of all tested probiotics, except Streptococcus salivarius, showed excellent antimicrobial activities. All target pathogens were killed within 4 to 24 h at twice the MIC of oraCMU and oraCMS1, which showed the highest antimicrobial activities against M. catarrhalis. The antimicrobial substances that affected different target pathogens were different. Both oraCMU and oraCMS1 showed excellent abilities to inhibit biofilm formation and remove preformed biofilms. Our results suggest that the W. cibaria probiotics offer new possibilities for the prevention and treatment of bacterial URTIs.

Tonsillopharyngitis 1994

1994 ◽  
Vol 15 (5) ◽  
pp. 185-191
Author(s):  
Floyd W. Denny
Keyword(s):  
Respiratory Tract ◽  
Respiratory Tract Infections ◽  
Antimicrobial Agents ◽  
Respiratory Infections ◽  
Upper Respiratory Tract Infections ◽  
Acute Respiratory Infections ◽  
Upper Respiratory Tract ◽  
Upper Respiratory ◽  
Major Factors ◽  
Tract Infections

Acute infections of the upper respiratory tract, including those of the tonsils and pharynx, are the most common affliction of humans; their tendency to occur with much greater frequency in children makes them especially important to the pediatrician. A host of microbial agents can cause these infections, but only a few are responsive to antimicrobial agents. Because of the paucity of definitive laboratory tools that allow easy recognition of the cause of most acute respiratory infections, it is important for the practicing pediatrician to have other methods to aid in the clinical management of children who have these infections. This review will discuss the etiology and epidemiology of acute respiratory infections that involve primarily the tonsils and pharynx, with emphasis on how this knowledge can guide clinicians in their management. The groundwork for this approach will be laid by suggesting a classification of upper respiratory tract infections that involve the tonsils and pharynx. Causative agents will be enumerated and put into perspective. The major factors associated with the occurrence of acute upper respiratory tract infections will be discussed. Finally, treatment of the patient who has tonsillopharyngitis will be presented. Uncomplicated acute tonsillopharyngitis will be emphasized primarily and the role of complications only mentioned.

Sign in / Sign up

Export Citation Format

Share Document